| Patient | Robert Falcon Scott |
|---|---|
| Date of birth | 1984-06-06 |
| Identifiers | MRN HR-EX002-SYN; SSN (made up) 000-02-6713 |
| Document date | 2026-01-13 |
| Author | Ottilie Harrow-Mbeki, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for new patient pre-expedition medical assessment before a long Antarctic expedition: history, examination, ECG, blood tests, mental health and alcohol screening, an elevated blood pressure, tobacco counseling, and a wilderness and expedition medicine referral. [S]
Sodium: 140 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.92 mg/dL; Fasting glucose: 92 mg/dL; Total cholesterol: 196 mg/dL; HDL cholesterol: 52 mg/dL; LDL cholesterol: 122 mg/dL; Triglycerides: 110 mg/dL; HbA1c: 5.3%; TSH: 2.1 mIU/L; Hemoglobin: 15.1 g/dL; eGFR: 107 mL/min/1.73 m²; PHQ-9: 3; GAD-7: 4; AUDIT-C: 3. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-01-13 | Body height | 173 | cm | S |
| 2026-01-13 | Body weight | 72.5 | kg | S |
| 2026-01-13 | Body mass index (BMI) [Ratio] | 24.2 | kg/m2 | S |
| 2026-01-13 | Systolic blood pressure | 144 | mm[Hg] | S |
| 2026-01-13 | Diastolic blood pressure | 90 | mm[Hg] | S |
| 2026-01-13 | Heart rate | 68 | /min | S |
| 2026-01-13 | Respiratory rate | 14 | /min | S |
| 2026-01-13 | Body temperature | 36.6 | Cel | S |
| 2026-01-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-01-13 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 136-145 mmol/L | Normal | S |
| 2026-01-13 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-01-13 | Creatinine [Mass/volume] in Serum or Plasma | 0.92 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-01-13 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-01-13 | Cholesterol [Mass/volume] in Serum or Plasma | 196 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-01-13 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 52 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-01-13 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 122 | mg/dL | Below 130 | Normal | S |
| 2026-01-13 | Triglyceride [Mass/volume] in Serum or Plasma | 110 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-01-13 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.3 | % | <=5.6% | Normal | S |
| 2026-01-13 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-01-13 | Hemoglobin [Mass/volume] in Blood | 15.1 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 2026-01-13 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 107 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 2026-01-13 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 2026-01-13 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 4 | {score} | S | ||
| 2026-01-13 | Total score [AUDIT-C] | 3 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Varenicline 1 mg tablet, one tablet by mouth twice a day after a one-week starter titration (0.5 mg once daily for 3 days, then twice daily for 4 days) | twice a day after titration | Oral route | 2026-01-13 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Elevated blood pressure at a pre-expedition medical assessment, 144/90 mmHg in the office without symptoms; hypertension not yet confirmed; one week of home readings requested | active | confirmed | R03.0 | S — Synthetic presenting finding at the pre-expedition assessment; no blood pressure from his lifetime is known. Superseded at the second visit by the confirmed diagnosis. |
| Nicotine dependence, pipe tobacco: about 25 g a week since his early twenties; first pipe within an hour of waking; has never tried to stop | active | confirmed | F17.290 | S — Synthetic modern coding anchored to his documented tobacco use on a sledge journey; the amount and pattern are synthetic. |
| Personal history of scurvy on a long polar sledge journey in his mid-thirties, with red gums and swollen ankles and legs, treated with fresh seal meat, and full recovery; months on preserved food again ahead | active | confirmed | Z86.39 | S — Synthetic modern coding of his documented scurvy, kept on the list because the expedition will put him at risk again. |